Biomarkers Predicting Antidepressant Treatment Response: How Can We Advance the Field?

Common Genetic Variation and Antidepressant Efficacy in Major Depressive Disorder: A Meta-Analysis of Three Genome-Wide Pharmacogenetic Studies

(2013) et al.   AMERICAN JOURNAL OF PSYCHIATRY

Shared genetics among major psychiatric disorders

(2013) Alessandro Serretti et al.   LANCET

Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis

(2013)   LANCET

FKBP5 genetic variation

(2013) Katarzyna A. Ellsworth et al.   Pharmacogenetics and Genomics

Toward Clinically Useful Neuroimaging in Depression Treatment

(2012) Greg J. Siegle et al.   ARCHIVES OF GENERAL PSYCHIATRY

Comprehending depression through proteomics

(2012) Daniel Martins-de-Souza   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Proteomic and metabolomic profiling reveals time-dependent changes in hippocampal metabolism upon paroxetine treatment and biomarker candidates

(2012) Christian Webhofer et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

(2012) Christopher J L Murray et al.   LANCET

HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity

(2012) Mitsumasa Kurita et al.   NATURE NEUROSCIENCE

Epigenetics of the Depressed Brain: Role of Histone Acetylation and Methylation

(2012) HaoSheng Sun et al.   NEUROPSYCHOPHARMACOLOGY

Genome-wide miRNA expression profiling of human lymphoblastoid cell lines identifies tentative SSRI antidepressant response biomarkers

(2012) Keren Oved et al.   PHARMACOGENOMICS

Pharmacoproteomic investigation into antidepressant response in two mouse inbred strains

(2012) Karim Malki et al.   PROTEOMICS

Are We Getting Closer to Valid Translational Models for Major Depression?

(2012) O. Berton et al.   SCIENCE

Predictors of remission in depression to individual and combined treatments (PReDICT): study protocol for a randomized controlled trial

(2012) Boadie W Dunlop et al.   Trials

Convergent animal and human evidence suggests the activin/inhibin pathway to be involved in antidepressant response

(2012) K Ganea et al.   Translational Psychiatry

Epigenetic Mechanisms of Depression and Antidepressant Action

(2011) Vincent Vialou et al.   Annual Review of Pharmacology and Toxicology

The economic cost of brain disorders in Europe

(2011) J. Olesen et al.   EUROPEAN JOURNAL OF NEUROLOGY

Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy

(2011) Stefano Porcelli et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Surrogate markers of treatment outcome in major depressive disorder

(2011) George I. Papakostas   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Little things on which happiness depends: microRNAs as novel therapeutic targets for the treatment of anxiety and depression

(2011) R M O'Connor et al.   MOLECULAR PSYCHIATRY

MicroRNAs and depression

(2011) Sophie Mouillet-Richard et al.   NEUROBIOLOGY OF DISEASE

The Neuronal Transporter Gene SLC6A15 Confers Risk to Major Depression

(2011) Martin A. Kohli et al.   NEURON

Adjuvant Trastuzumab in HER2-Positive Breast Cancer

(2011) Dennis Slamon et al.   NEW ENGLAND JOURNAL OF MEDICINE

MicroRNA Expression Profiling Reveals MiRNA Families Regulating Specific Biological Pathways in Mouse Frontal Cortex and Hippocampus

(2011) Juuso Juhila et al.   PLoS One

Gene expression biomarkers of response to citalopram treatment in major depressive disorder

(2011) F Mamdani et al.   Translational Psychiatry

Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept

(2011) R Kaddurah-Daouk et al.   Translational Psychiatry

Personalized Medicine for Depression: Can We Match Patients With Treatments?

(2010) Gregory E. Simon et al.   AMERICAN JOURNAL OF PSYCHIATRY

Convergent Animal and Human Evidence Suggests a Role of PPM1A Gene in Response to Antidepressants

(2010) Karim Malki et al.   BIOLOGICAL PSYCHIATRY

Pharmacogenetics of antidepressant response

(2010) Robert Keers et al.   Expert Review of Neurotherapeutics

Endophenotype: a conceptual analysis

(2010) K S Kendler et al.   MOLECULAR PSYCHIATRY

Biomarkers to Predict Antidepressant Response

(2010) Andrew F. Leuchter et al.   Current Psychiatry Reports

A Genomewide Association Study Points to Multiple Loci That Predict Antidepressant Drug Treatment Outcome in Depression

(2009) Marcus Ising et al.   ARCHIVES OF GENERAL PSYCHIATRY

Pharmacogenetics in Psychiatry - A Useful Clinical Tool or Wishful Thinking for the Future?

(2009) J. Kirchheiner et al.   CURRENT PHARMACEUTICAL DESIGN

The role of proteomics in depression research

(2009) Daniel Martins-de-Souza et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

Selecting Among Second-Step Antidepressant Medication Monotherapies

(2008) A. John Rush et al.   ARCHIVES OF GENERAL PSYCHIATRY

The FKBP5-Gene in Depression and Treatment Response—an Association Study in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Cohort

(2008) Magnus Lekman et al.   BIOLOGICAL PSYCHIATRY

How can we realize the promise of personalized antidepressant medicines?

(2008) Florian Holsboer   NATURE REVIEWS NEUROSCIENCE

Polymorphisms in the Drug Transporter Gene ABCB1 Predict Antidepressant Treatment Response in Depression

(2008) Manfred Uhr et al.   NEURON

Pharmacogenomics: The Promise of Personalized Medicine for CNS Disorders

(2008) Jose de Leon   NEUROPSYCHOPHARMACOLOGY